AccessPak for HIV PEP Expanded with Kaletra and Xultophy
Determining the interaction of AccessPak for HIV PEP Expanded with Kaletra and Xultophy and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: emtricitabine / lopinavir / ritonavir / tenofovir
Brand name: AccessPak for HIV PEP Expanded with Kaletra
Synonyms: n.a.
Generic Name: insulin degludec / liraglutide
Brand name: Xultophy
Synonyms: Xultophy 100/3.6
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- AccessPak for HIV PEP Expanded with Kaletra-Xultophy 100/3.6
- AccessPak for HIV PEP Expanded with Kaletra-Xuriden
- AccessPak for HIV PEP Expanded with Kaletra-Xylocaine
- AccessPak for HIV PEP Expanded with Kaletra-Xylocaine (Cardiac)
- AccessPak for HIV PEP Expanded with Kaletra-Xylocaine (Lidocaine Injection Solution (Anesthetic))
- AccessPak for HIV PEP Expanded with Kaletra-Xylocaine (Lidocaine Oral Liquid and Solution)
- Xultophy-AccessPak for HIV PEP Expanded with Viracept
- Xultophy-Accolate
- Xultophy-Accretropin
- Xultophy-Accucaine
- Xultophy-AccuHist Drops
- Xultophy-AccuHist PDX Drops